Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 3/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.32 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.32 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.32 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9301973 | 0.80 | OPRM1 (0.53) | FDPSOPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL9303011 | 0.79 | FDPS (0.54) | FDPS | |
| SCHEMBL9302085 | 0.77 | FDPS (0.44) | FDPS | |
| SCHEMBL9302739 | 0.76 | FDPS (0.56) | FDPS | |
| SCHEMBL9302962 | 0.76 | FDPS (0.50) | FDPSOPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL9300682 | 0.74 | FDPS (0.48) | FDPSOPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL7849180 | 0.74 | CHRNA7 (0.39) | OPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL9301189 | 0.74 | FDPS (0.58) | FDPS | |
| SCHEMBL9301634 | 0.73 | FDPS (0.52) | FDPS | |
| SCHEMBL9300740 | 0.73 | FDPS (0.52) | FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5350743-A | Treatment of osteoporosis | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1994-09-27 | — | — | US | disclosed |
| EP-0498424-A1 | Bisphosphonic acid derivatives and bone resorption inhibitors containing them | Kaken Pharmaceutical Co., Ltd. (JP) | 1992-08-12 | — | — | EP | disclosed |